Chelsea Counsel Company’s iShares Biotechnology ETF IBB Stock Holding History

Chelsea Counsel Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$666K	Sell	3,500 -300	-8%	-$51.6K	0.28%	57
2026 Q1	$642K	Hold	3,800	–	–	0.29%	55
2025 Q4	$641K	Sell	3,800 -30	-0.8%	-$4.87K	0.28%	59
2025 Q3	$553K	Hold	3,830	–	–	0.25%	65
2025 Q2	$485K	Hold	3,830	–	–	0.24%	68
2025 Q1	$490K	Hold	3,830	–	–	0.27%	62
2024 Q4	$506K	Sell	3,830 -1,050	-22%	-$148K	0.26%	63
2024 Q3	$711K	Sell	4,880 -730	-13%	-$106K	0.35%	59
2024 Q2	$770K	Sell	5,610 -100	-2%	-$13.3K	0.38%	52
2024 Q1	$784K	Hold	5,710	–	–	0.44%	41
2023 Q4	$776K	Hold	5,710	–	–	0.41%	49
2023 Q3	$699K	Hold	5,710	–	–	0.36%	58
2023 Q2	$725K	Buy	5,710 +130	+2%	+$16.9K	0.36%	56
2023 Q1	$721K	Sell	5,580 -450	-7%	-$58.9K	0.35%	61
2022 Q4	$792K	Buy	+6,030	New	+$779K	0.4%	62

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Chelsea Counsel Company's IBB Position: Q2 2026 in Review

Chelsea Counsel Company reduced its iShares Biotechnology ETF (IBB) stake by 7.9% in Q2 2026, selling an estimated $51.6K and leaving 3,500 shares worth $666K. The position accounts for 0.28% of the portfolio, ranked #57.

Chelsea Counsel Company first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. The position peaked at $792K in Q4 2022. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Chelsea Counsel Company held 3,500 shares of iShares Biotechnology ETF worth $666K as of Q2 2026.
Chelsea Counsel Company sold 300 iShares Biotechnology ETF shares in Q2 2026, an estimated $51.6K.
iShares Biotechnology ETF made up 0.28% of Chelsea Counsel Company's portfolio in Q2 2026, its #57 holding.
Chelsea Counsel Company first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
Chelsea Counsel Company's iShares Biotechnology ETF position peaked at $792K in Q4 2022.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Chelsea Counsel Company's 13F filing for Q2 2026, filed 12 Aug 2026.